Novo Nordisk in $1.3 bln deal to buy hypertension drug

Clora Volkman
October 17, 2023

Liked this post? Share with others!

Novo Nordisk https://www.reuters.com/markets/companies/NOVOb.CO” target=”_blank” rel=”noopener”>(NOVOb.CO) has agreed to buy ocedurenone, a drug for uncontrolled hypertension with potential application in cardiovascular and kidney disease, from KBP Biosciences …
Read More

Subscribe to our newsletter

Collect visitor’s submissions and store it directly in your Elementor account, or integrate your favorite marketing & CRM tools.

Do you want to boost your business today?

This is your chance to invite visitors to contact you. Tell them you’ll be happy to answer all their questions as soon as possible.